Detalhe da pesquisa
1.
Phase 3 Trial of Selpercatinib in Advanced RET-Mutant Medullary Thyroid Cancer.
N Engl J Med
; 389(20): 1851-1861, 2023 Nov 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37870969
2.
Cabozantinib for previously treated radioiodine-refractory differentiated thyroid cancer: Updated results from the phase 3 COSMIC-311 trial.
Cancer
; 128(24): 4203-4212, 2022 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36259380
3.
In patients with well-differentiated neuroendocrine tumours, there is no apparent benefit of somatostatin analogues after disease control by peptide receptor radionuclide therapy.
Eur J Nucl Med Mol Imaging
; 49(11): 3841-3851, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35503379
4.
Stereotactic radiotherapy is a useful treatment option for patients with medullary thyroid cancer.
BMC Endocr Disord
; 21(1): 160, 2021 Aug 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34372848
5.
Impact of the Tumor Microenvironment on the Gene Expression Profile in Papillary Thyroid Cancer.
Pathobiology
; 87(2): 143-154, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32320975
6.
Differences in Gene Expression Profile of Primary Tumors in Metastatic and Non-Metastatic Papillary Thyroid Carcinoma-Do They Exist?
Int J Mol Sci
; 21(13)2020 Jun 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-32610693
7.
Novel TG-FGFR1 and TRIM33-NTRK1 transcript fusions in papillary thyroid carcinoma.
Genes Chromosomes Cancer
; 58(8): 558-566, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30664823
8.
Paediatric-onset and adult-onset Graves' disease share multiple genetic risk factors.
Clin Endocrinol (Oxf)
; 90(2): 320-327, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30358895
9.
Heterogeneity of Thyroid Cancer.
Pathobiology
; 85(1-2): 117-129, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29408820
10.
Coexistence of TERT Promoter Mutations and the BRAF V600E Alteration and Its Impact on Histopathological Features of Papillary Thyroid Carcinoma in a Selected Series of Polish Patients.
Int J Mol Sci
; 19(9)2018 Sep 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30200646
11.
Gender-dependent and age-of-onset-specific association of the rs11675434 single-nucleotide polymorphism near TPO with susceptibility to Graves' ophthalmopathy.
J Hum Genet
; 62(3): 373-377, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-27829681
12.
Current Advances in Thyroid Cancer Management. Are We Ready for the Epidemic Rise of Diagnoses?
Int J Mol Sci
; 18(8)2017 Aug 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-28829399
13.
Gene Expression (mRNA) Markers for Differentiating between Malignant and Benign Follicular Thyroid Tumours.
Int J Mol Sci
; 18(6)2017 Jun 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28574441
14.
Current treatment options for gastroenteropancreatic neuroendocrine tumors with a focus on the role of lanreotide.
Contemp Oncol (Pozn)
; 21(2): 115-122, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28947880
15.
Gene signature of the post-Chernobyl papillary thyroid cancer.
Eur J Nucl Med Mol Imaging
; 43(7): 1267-77, 2016 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26810418
16.
Population pharmacokinetic analysis of lenvatinib in healthy subjects and patients with cancer.
Br J Clin Pharmacol
; 81(6): 1124-33, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26879594
17.
Impact of SNPs on methylation readouts by Illumina Infinium HumanMethylation450 BeadChip Array: implications for comparative population studies.
BMC Genomics
; 16: 1003, 2015 Nov 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-26607064
18.
A phase 2 trial of lenvatinib (E7080) in advanced, progressive, radioiodine-refractory, differentiated thyroid cancer: A clinical outcomes and biomarker assessment.
Cancer
; 121(16): 2749-56, 2015 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25913680
19.
Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial.
Lancet
; 384(9940): 319-28, 2014 Jul 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-24768112
20.
Combination chemotherapy in advanced adrenocortical carcinoma.
N Engl J Med
; 366(23): 2189-97, 2012 Jun 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-22551107